ArticleRheumatology and therapy2024

Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials.

Jeffrey R Curtis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.